MFDS — authorised 29 September 2000
- Marketing authorisation holder: ALPHARMA US PHARMS
- Status: likely_approved
🇰🇷 Propadrine in South Korea
MFDS authorised Propadrine on 29 September 2000
Marketing authorisation
Propadrine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Propadrine approved in South Korea?
Yes. MFDS authorised it on 29 September 2000.
Who is the marketing authorisation holder for Propadrine in South Korea?
ALPHARMA US PHARMS holds the South Korean marketing authorisation.